Antimicrobial peptides in skin diseases
Date
2022-03
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
BRAC University
Abstract
Skin diseases, including inflammatory and infections, result from disruptions in the skin's
barrier. Antimicrobial peptides (AMPs) have recently gained attention as potential treatments
for inflammatory, soft skin tissue and wound infections. This review discusses AMPs in skin
diseases. It highlights the therapeutic properties of AMPs and their potential utility in treating
skin disorders. Even though only a few AMPs, such as oritavancin and daptomycin, have been
approved for use in clinical trials. Moreover, omiganan, pexiganan, and DPK-060 have also
been studied extensively for treating skin problems. This paper also mentions some strategies
to increase AMPs' clinical trial success rate.
Description
Cataloged from PDF version of thesis report.
Includes bibliographical references (pages 45-52).
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Includes bibliographical references (pages 45-52).
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Keywords
Skin diseases, inflammatory disease, Soft skin tissue infections, Antimicrobial peptides, Therapeutic agents